Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Journal of Personality Assessment
|
February 1, 1995
Personal problem-solving scoring of the TAT: sensitivity to training
G F Roman, A L Date, M Weisbrod
Journal of Clinical Pathology
|
February 1, 1988
Simplified screening procedure for detecting lupus inhibitor
J Gibson, E Starling, L Date, et al.
HIV Medicine
|
June 22, 2010
Doctor-patient concordance during HIV treatment switching decision-making
C Clucas, R Harding, F C Lampe, et al.
Pathogens (Basel, Switzerland)
|
July 26, 2020
The Epstein-Barr Virus-Encoded EBNA1 Protein Activates the Bone Morphogenic Protein (BMP) Signalling Pathway to Promote Carcinoma Cell Migration
Hannah E Bridgewater, Kathryn L Date, John D O'Neil, et al.
Australian and New Zealand Journal of Medicine
|
October 1, 1989
A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin
J Gibson, L Date, D E Joshua, et al.
BMJ Open
|
January 14, 2025
Randomised, placebo-controlled, double-blinded, four-way crossover trial to demonstrate the comparative pharmacodynamic equivalence of a non-invasive diagnostic test for adrenal insufficiency in a healthy population: the STARLIT-2 study protocol
Kathryn L Date, Kathleen Baster, Sharon L Caunt, et al.
The Journal of General Virology
|
October 22, 2008
Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro
John D O'Neil, Thomas J Owen, Victoria H J Wood, et al.
Molecular Cancer
|
January 7, 2010
Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation
Robert Valentine, Christopher W Dawson, Chunfang Hu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Journal of Personality Assessment
|
February 1, 1995
Personal problem-solving scoring of the TAT: sensitivity to training
G F Roman, A L Date, M Weisbrod
Journal of Clinical Pathology
|
February 1, 1988
Simplified screening procedure for detecting lupus inhibitor
J Gibson, E Starling, L Date, et al.
HIV Medicine
|
June 22, 2010
Doctor-patient concordance during HIV treatment switching decision-making
C Clucas, R Harding, F C Lampe, et al.
Pathogens (Basel, Switzerland)
|
July 26, 2020
The Epstein-Barr Virus-Encoded EBNA1 Protein Activates the Bone Morphogenic Protein (BMP) Signalling Pathway to Promote Carcinoma Cell Migration
Hannah E Bridgewater, Kathryn L Date, John D O'Neil, et al.
Australian and New Zealand Journal of Medicine
|
October 1, 1989
A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin
J Gibson, L Date, D E Joshua, et al.
BMJ Open
|
January 14, 2025
Randomised, placebo-controlled, double-blinded, four-way crossover trial to demonstrate the comparative pharmacodynamic equivalence of a non-invasive diagnostic test for adrenal insufficiency in a healthy population: the STARLIT-2 study protocol
Kathryn L Date, Kathleen Baster, Sharon L Caunt, et al.
The Journal of General Virology
|
October 22, 2008
Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro
John D O'Neil, Thomas J Owen, Victoria H J Wood, et al.
Molecular Cancer
|
January 7, 2010
Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation
Robert Valentine, Christopher W Dawson, Chunfang Hu, et al.
Page
of 1